z-logo
open-access-imgOpen Access
Granulocyte-Colony Stimulating Factor Producing Extrahepatic Bile Duct Carcinoma: A Case Report
Author(s) -
Masayuki Sho,
Shoichi Kinoshita,
Kinta Hatakeyama,
Yasunori Enomoto,
Takahiro Akahori,
Minako Nagai,
Satoshi Nishiwada,
Kota Nakamura,
Kohei Morita,
Chiho Ohbayashi
Publication year - 2018
Publication title -
international surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.132
H-Index - 39
eISSN - 2520-2456
pISSN - 0020-8868
DOI - 10.9738/intsurg-d-16-00168.1
Subject(s) - medicine , gemcitabine , chemotherapy , bile duct , bile duct cancer , cisplatin , granulocyte colony stimulating factor , granulocyte , oncology , gastroenterology , pathology
Granulocyte-colony stimulating factor (G-CSF) producing tumors are rare diseases and occur in various organs. However, due to the rarity of these tumors, the precise biologic characteristics and optimal therapeutic strategies are largely unknown. Previous studies have shown the extremely high malignant potential and aggressive clinical features of G-CSF producing tumors, regardless of the histologic type and tumor location. We present the case of a 59-year-old female who had large tumor in extrahepatic bile duct. She underwent surgery and adjuvant chemotherapy. Then, she also received gemcitabine and cisplatin combination chemotherapy for metastatic lesions. The therapy showed a certain effect and she survived for 17 months after surgery. To the best of our knowledge, this is the first report of multidisciplinary treatment with surgery and systemic chemotherapy for G-CSF producing extrahepatic bile duct cancer. This study highlights the potential of multidisciplinary treatment even for this lethal disease condition.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom